Development and Validation of mutiplex assay for identifying and differentiating serotypes of botulinum nerotoxins (BoNT)

The Department of Homeland Security, through its Office of Procurement Operations, awarded Contract Number HSHQDC-14-C-00042 to Radix Biosolutions Ltd. on June 16, 2014. This contract, valid for a two-year period, focuses on the development and validation of a multiplex assay designed to identify and differentiate serotypes of botulinum neurotoxins (BoNT). The work is to be performed in Georgetown, Texas, under the NAICS code 541712, which relates to research and development in the physical, engineering, and life sciences fields. The award was made as a sole source procurement, with justification provided for this method of acquisition. The contract is managed by the Department of Homeland Security's Contract Administration Services Division, located in Washington, DC. Key points of contact for this contract include Contracting Officer Michael E. Jones and Contract Specialist Danette Williams, both available for correspondence related to this procurement. This project aims to enhance capabilities for detecting and classifying BoNT serotypes, which is critical for homeland security and public health preparedness.